- Home
- DNLI vs GDV Comparison
DNLI vs GDV Comparison
Compare DNLI & GDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- GDV
- Stock Information
- Founded
- DNLI 2013
- GDV 2003
- Country
- DNLI United States
- GDV United States
- Employees
- DNLI N/A
- GDV N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- GDV Investment Managers
- Sector
- DNLI Health Care
- GDV Finance
- Exchange
- DNLI Nasdaq
- GDV Nasdaq
- Market Cap
- DNLI 2.1B
- GDV 2.3B
- IPO Year
- DNLI 2017
- GDV N/A
- Fundamental
- Price
- DNLI $13.60
- GDV $24.18
- Analyst Decision
- DNLI Strong Buy
- GDV
- Analyst Count
- DNLI 16
- GDV 0
- Target Price
- DNLI $37.57
- GDV N/A
- AVG Volume (30 Days)
- DNLI 1.3M
- GDV 186.0K
- Earning Date
- DNLI 05-06-2025
- GDV 01-01-0001
- Dividend Yield
- DNLI N/A
- GDV 5.81%
- EPS Growth
- DNLI N/A
- GDV N/A
- EPS
- DNLI N/A
- GDV N/A
- Revenue
- DNLI N/A
- GDV N/A
- Revenue This Year
- DNLI N/A
- GDV N/A
- Revenue Next Year
- DNLI $497.02
- GDV N/A
- P/E Ratio
- DNLI N/A
- GDV N/A
- Revenue Growth
- DNLI N/A
- GDV N/A
- 52 Week Low
- DNLI $13.30
- GDV $18.04
- 52 Week High
- DNLI $33.33
- GDV $23.00
- Technical
- Relative Strength Index (RSI)
- DNLI 34.19
- GDV 47.02
- Support Level
- DNLI $13.67
- GDV $23.95
- Resistance Level
- DNLI $14.84
- GDV $24.59
- Average True Range (ATR)
- DNLI 0.77
- GDV 0.28
- MACD
- DNLI 0.12
- GDV 0.05
- Stochastic Oscillator
- DNLI 9.90
- GDV 64.04
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food & Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.